Back to medications
Medication monograph

risdiplam

SMN2 Splicing ModifiersNeuromuscular AgentsSurvival Motor Neuron-2-directed RNA InteractionSurvival of Motor Neuron 2 Splicing Modifier

Clinical reference

Product monograph

EVRYSDI- risdiplam powder, for solutionEVRYSDI- risdiplam tablet

Brands & formulations

Family members

EVRYSDI

Marketed
0.75 MGORALPOWDER FOR SOLUTION[ "risdiplam" ]
Product monograph

Classification

Chemical class
SMN2 Splicing Modifiers
Clinical class
Neuromuscular Agents
Banks class
Survival Motor Neuron-2-directed RNA Interaction, Survival of Motor Neuron 2 Splicing Modifier